Q1 is in the books, and stocks are heading into Q2 with some major accomplishments. Can the market rally keep raging? And where you should be positioned going into the second quarter. Plus… what it really costs to craft these diabetes drugs. A new study pointing to a $5 price tag for a month’s worth of one blockbuster GLP-1 drug. The dollar dichotemy… and if prices will come down for the public.
 
Fast Money Disclaimer

Stocks Close Out A Big First Quarter… And The True Cost Of Diabetes Drugs 3/28/24

Hosted by Melissa Lee and a roundtable of top traders, “Fast Money” breaks through the noise of the day, to deliver the actionable news that matters most to investors. Fast Money airs weeknights at 5p ET on CNBC. Visit http://fastmoney.cnbc.com for additional information.

Business

Investing

Careers

Management & Marketing

Business News

Shopping

News

Shares of Disney tumble as the media giant looks to make its streaming business profitable. 
The hurdles they face, and how a consumer under pressure will impact the company. Plus relying on Nvidia. Can the AI trade continue its run? Or does a pullback in the name spell trouble for the broader market?

Fast Money Disclaimer

Magic Lost At Disney? And Has AI Come Too Far, Too Fast? 5/7/24

10-year yields are down about 25 basis points from their recent highs, but are they falling for the right reasons? And what does the move mean for the markets? Plus, former Starbucks CEO Howard Schultz weighing in on the company’s latest earnings report and the leadership of the man he chose to replace him. How will his comments impact the company now? 

Fast Money Disclaimer

Digesting the Drop in Rates, and the Latest Headache for Starbucks 5/6/24

Shares of Apple surging after the company announced the biggest share buyback in history, but was the news just a bit of financial engineering to distract investors from slowing sales? Plus Starbucks continued to drop after its disappointing earnings report. Is this stock actually so bad it's good? 
Fast Money Disclaimer

Apple's Buyback Distraction? And Starbucks' Really Rough Week 5/3/24

How can investors use the timeless investing strategies and sage teachings of the iconic Warren Buffett to make their own investing decisions? What does the portfolio of Berkshire-owned companies and stocks say about your own portfolio? CNBC Pro goes on a deep dive of all things Buffett with a longtime Berkshire shareholder and follower. CNBC’s Dominic Chu interviews Berkshire investor Bill Stone, the CIO at Glenview Trust Company, in this special CNBC Pro Talk ahead of the 2024 Berkshire annual shareholders meeting. CNBC Pro’s Yun Li also joins to preview Berkshire’s annual meeting and what investors can expect from the Oracle of Omaha.

CNBC Pro Talks features one-on-one interviews with Wall Street’s top investors, smartest traders and rising stars. CNBC’s Dominic Chu finds out what makes them tick, what makes them money, and how you can follow in their footsteps. CNBC Pro Talks is a monthly interview series that’s part of CNBC’s premium subscription service, CNBC Pro. To hear the full Pro Talk interview—including specific stock picks and investment strategies—listeners can subscribe to [cnbc.com/protalks].

CNBC Pro Talks: How to profit from Warren Buffett's methods in investing and life 5/3/24

Apple on the move after its results. We’re diving into the numbers and the call from the iPhone maker. Plus shedding the pounds and the prices. Novo Nordisk lowering prices for its blockbuster weight loss drugs. How an increase in competition is tipping the scales in the space.

Fast Money Disclaimer

Stocks Close Out A Big First Quarter… And The True Cost Of Diabetes Drugs 3/28/24

Download our free app to listen on your phone